Lacrison® is the preparation of Loteprednol etabonate which is belongs to a group of medicines known as steroidal anti-inflammatory drugs. Lacrison® is used to treat inflammation of the eye, after surgery.
It acts by reducing inflammation and eases the symptoms. Because it is used in low doses directly where it is needed, its action is only at this place.
Lacrison Ophthalmic Suspension
Shake the bottle vigorously before using
Steroid responsive disease treatment: Apply 1 to 2 drops of Loteprednolinto the conjunctival sac of the affected eye(s) four times daily. During the initial treatment within the first week, the dosing may be increased, up to 1 drop every hour, if necessary. Care should be taken not to discontinue therapy prematurely.
Post-Operative Inflammation: Apply 1 to 2 drops of Loteprednolinto the conjunctival sac of the operated eye(s) four times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the post-operative period.